The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons

• DOI: 10.1016/j.celrep.2021.109697
• Publication Date: 2021-09-14T21:36:24Z
• Authors: Marianna Tolve; Ayse Ulusoy; Nikolaos Patikas; K. Ushna S. Islam; Gabriela O. Bodea; Ece Öztürk; Bianca Broske; Astrid Mentani; Antonia Wagener; Karen M.J. van Loo; Stefan Britsch; Pengtao Liu; Walid T. Khaled; Emmanouil Metzako...; Stephan L. Baader; Donato A. Di Monte; Sandra Blaess
• Keywords: Male; QH301-705.5; alpha-synuclein; Dopamine; Induced Pluripotent Stem Cells; iPSCs; Mice; 03 medical and health sciences; deficiency [Repressor Proteins]; circuits; metabolism [Substantia Nigra]; Animals; Humans; ddc:610; metabolism [Dopamine]; metabolism [alpha-Synuclein]; Biology (General); development; pathology [Substantia Nigra]; mouse; transcription factor; metabolism [Repressor Proteins]; Mice, Knockout; 0303 health sciences; dopaminergic neurons; Behavior, Animal; behavior; Dopaminergic Neurons; metabolism [Dopaminergic Neurons]; metabolism [Ventral Tegmental Area]; Ventral Tegmental Area; neurodegeneration; Brain; cytology [Induced Pluripotent Stem Cells]; pathology [Ventral Tegmental Area]; neuronal diversity; metabolism [Induced Pluripotent Stem Cells]; Repressor Proteins; Substantia Nigra; genetics [Repressor Proteins]; metabolism [Brain]; genetics [alpha-Synuclein]; alpha-Synuclein; Transcriptome

Cell reports 36(11), 109697 (2021). doi:10.1016/j.celrep.2021.109697<br/>Published by Elsevier, [New York, NY]<br/>